Prolonged Complete Remission of Relapsing Acute Promyelocytic Leukemia Induced by 13-cis-retinoic Acid

References

• Fibach E., Landau T., Sachs L. Normal differentiation of myeloid leukemic cells induced by a differentiation-inducing protein. Nature 1972; 37: 276–278
   Google Scholar
• Hoffman S. J., Robinson W. A. Use of differentiation-inducing agents in the myelodysplastic syndrome and acute non-lymphocytic leukemia. Am. J. Hematol 1988; 28: 124–127
   PubMed Web of Science ®Google Scholar
• Huang Meng-Er, Yu-Chen Y E., Shu-Rong C., et al. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Larson R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M., Rowley J. D. Evidence for a 15:17 translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 1984; 76: 827–841
   PubMed Web of Science ®Google Scholar
• Bernard J., Weil M., Boiron M., Jacquillat C., Flandrin G., Gemon M. F. Acute promyelocytic leukemia. Results of treatment with daunorubicin. Blood 1973; 41: 489–496
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Walters R. S., et al. Acute promyelocytic leukemia: The MD Anderson Hospital experience. Am. J. Med. 1986; 80: 789–797
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Walters R. S., et al. Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer. 1987; 59: 1258–1263
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocyte leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr, Frankel S. R., Miller W. H., Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Entjl. J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Zigmond S. H., Hirsch J. R. Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 1973; 137: 387–410
   PubMed Web of Science ®Google Scholar
• Matzner Y., Partridge R. E. H., Babior B. M. A chemotactic inhibitor in synovial fluid. Immunology 1983; 49: 131–138
   PubMed Web of Science ®Google Scholar
• Matzner Y., Brass L. M., McMurrich B. J., Peters W. A., Andre-Schwarz J., Babior B. M. Expression of a chronic granulomatous disease-like defect by fluoride-exhausted neutrophils. Blood 1982; 60: 822–826
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Nail. Acad Sci. USA. 1980; 77: 2936–2940
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Collins S. J., Keene B. R. Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000–1004
   PubMed Web of Science ®Google Scholar
• Matzner Y., Gavison R., Rachmilewitz E. A., Fibach E. Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by di-methylsulfoxide and retinoic acid. Cell Differentiation 1987; 21: 261–269
   PubMedGoogle Scholar
• Wang Z. Y., Sun G. L., Lu J. X., Gu L. J., Huang M. E., Chen S. R. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China. Nouv. Rex. Fr. Hematol 1990; 32: 34–36
   PubMedGoogle Scholar
• Gallagher R. E., Lurie K. J., Leavitt R. D., Wiernick P. H. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alfa A interferon. Leuk. Res. 1987; 11: 609–619
   PubMed Web of Science ®Google Scholar
• Nervi C., Grippo J. F., Sherman M. I., George M. D., Jetten A. M. Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc. Natl. Acad. Sci. USA 1989; 86: 5854–8
   PubMed Web of Science ®Google Scholar
• Largman C., Detmer K., Corral J. C., Hack F. M., Lawrence J. Expression of retinoic acid receptor alpha mRNA in human leukemia cells. Blood 1989; 74: 99–102
   PubMed Web of Science ®Google Scholar
• Wang C., Curtis J. E., Minden M. D., McCulloch E. A. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264–269
   PubMed Web of Science ®Google Scholar
• Gallagher R. E., Said F., Pau I., Papenhausen P. R., Paietta E., Wiernik P. H. Expression of retinoic acid receptor alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid. Leukemia 1989; 3: 789–795
   PubMed Web of Science ®Google Scholar
• Chomienne C., Ballerini P., Balitrand N., et al. The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990; 4: 802–807
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Warrell R. P., Jr, Frankel S. R., et al. Novel retinoic acid receptor-alpha transcripts in acute promyelocytic fluctuations responsive to all-trans-retinoic acid. J. Natl. Cancer Inst. 1990; 82: 1932–1933
   PubMed Web of Science ®Google Scholar
• Longo L., Pandolfi P. P., Biondi A., et al. Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J. Exp. Med 1990; 172: 1571–1575
   PubMed Web of Science ®Google Scholar
• Lemons R. S., Eilender D., Waldmann R. A., et al. Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia. Genes Chromosome Cancer 1990; 2: 79–87
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–80
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Robertson Mueller K. A., Le Moyne Collins S. J. Retinoic acid receptors in myeloid leukemia: Characterization of receptors in retinoic acid-resistant K-562 cells. Blood 1991; 77: 340–347
   PubMed Web of Science ®Google Scholar
• Kitagawa S., Nojiri H., Nakamura M., Gallagher R. E., Saito M. Human myelogenous leukemia cell line HL-60 cells resistant to differentiation induction by retinoic acid. Decreased content of glycosphinogolipids and granulocytic differentiation by neolacto series ganglionsides. J. Bio. Chem. 1989; 264: 16149–16154
   PubMedGoogle Scholar
• Chomienne C., Ballerini P., Balitrand N., et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar